iShares GNMA Bond ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GNMA and other ETFs, options, and stocks.

About GNMA

GNMA tracks a market-value-weighted index of US mortgage pass-through securities issued by Government National Mortgage Association (GNMA), with 30- or 15-year maturities. 

Index-Tracked
BBgBarc US Universal TR USD
Index-TrackedBBgBarc US Universal TR USD
Category
Intermediate Government
CategoryIntermediate Government
Number of holdings
313
Number of holdings313
Inception Date
Feb 14, 2012
Inception DateFeb 14, 2012

What's in this fund

Sectors

As of August 21, 2025
Securitized Bonds92.70%
Cash and Equivalents7.30%

Top 10 Holdings (28.39% of total assets)

As of August 21, 2025
NameSymbol% Assets
BlackRock Cash Funds Treasury SL Agency—7.78%
Government National Mortgage Association 2%—3.45%
Government National Mortgage Association 2%—2.74%
Government National Mortgage Association 5.5%—2.39%
Government National Mortgage Association 2.5%—2.17%
Government National Mortgage Association 2%—2.13%
Government National Mortgage Association 6%—2.08%
Government National Mortgage Association 2%—1.92%
Government National Mortgage Association 2.5%—1.87%
Government National Mortgage Association 2.5%—1.86%

GNMA Key Statistics

AUM
369.07M
AUM369.07M
Price-Earnings ratio
—
Price-Earnings ratio—
30-Day yield
4.26
30-Day yield4.26
Average volume
20.03K
Average volume20.03K
High today
$44.12
High today$44.12
Low today
$43.97
Low today$43.97
Open price
$44.06
Open price$44.06
Volume
6.20K
Volume6.20K
52 Week high
$45.69
52 Week high$45.69
52 Week low
$42.00
52 Week low$42.00
Expense ratio
0.11
Expense ratio0.11
View Prospectus and Reports

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.